World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

Cortexyme is a Clinical Stage Biopharmaceutical company. It is a pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed and other degenerative diseases. The company is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients that causes neurodegeneration and other pathology in animal models. The headquarters is in USA.

C4 Therapeutics is a Biopharmaceutical company committed to transforming the treatment of cancer, neurological and other important diseases with novel early stage therapies that eliminate disease causing proteins. The company annual revenue is 21.38 million USD and 97 employees as on 2019. The headquarters is in USA.

Poseida Therapeutics is a Clinical Stage Biopharmaceutical company focused on gene engineering platform technologies and better treatments to patients with serious diseases with blood cancers like multiple myeloma, solid tumor cancers like prostate and breast cancer, and rare genetic diseases in the liver. The company estimated annual revenue is currently 32.6 million USD per year. The headquarters is in USA.

Y-mAbs Therapeutics is a Late Stage Clinical Biopharmaceutical company. It is focused on the development and commercialization of novel, antibody based therapeutic products for the treatment of cancer. The headquarters is in USA.

Nkarta is a Clinical Stage Biotechnology company improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. The company annual revenue is less 1 million USD and 70 employees as on 2019. The headquarters is in USA.

Applied Therapeutics is a Clinical Stage Biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. It is having 11 employees as on 2019. The headquarters is in USA.

Atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Headquarters is in Germany.

GH Research PLC is a clinical stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The headquarters is in Ireland.

Mersana Therapeutics is a Biopharmaceutical company specializing in the discovery and development of antibody drug conjugate (ADC) therapies to treat patients fighting cancer. The company total assets is 107.5 million USD as on 2019, total liabilities is 29.2 million USD as on 2019, annual revenue is 42.1 million USD as on 2019 and total equity is 78.3  million USD as on 2019.The headquarters is in USA.